

Hetu Kamisetty
Founder
Now Founder, Xaira Therapeutics
Latest on AI4S.fyiFunding · Apr 23, 2024 · founderXaira Therapeutics · Round (unnamed) · more than $1 billion in committed capitalPhotos come from each person's X account, their own site, lab or team page, a conference page that lists them as a speaker in the same role, or Wikimedia Commons under the licence credited, so some may be out of date. Anyone can ask for theirs to be replaced or removed. Contact →
Affiliations
Current
- Founder · Xaira Therapeutics
Also named in the companies' announcements: Meta / FAIR, Baker lab / IPD
Current roles come from these dated records, not from the bio below. Each links the page it was read from.
About
Hetu Kamisetty is a co-founder of Xaira Therapeutics and has been its chief technology officer since December 2024, after serving as senior vice president. Before Xaira he spent a decade at Meta on AI projects, including its early generative AI work, and before that was a postdoctoral fellow in David Baker's lab at the University of Washington, building self-supervised generative models of protein families for folding and design. He holds a PhD in machine learning from Carnegie Mellon, with a thesis on probabilistic models of proteins, and a B.Tech in computer science from IIT Madras.
Read on 2026-09-29; for current roles see Affiliations above. Read at: silicon.co.uk ↗ · xaira.com ↗
Founded
Xaira TherapeuticsDrug discovery · 1 round on record · Round (unnamed) more than $1 billion in committed capitalBackground: Meta and the Institute for Protein Design (co-founder) (as the company's own announcements put it)
Co-founders: David Baker, Marc Tessier-Lavigne
Nothing else on the record names them yet.
Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →
